Plishker M F, Chidambaram M, Berget P B
J Mol Biol. 1983 Oct 15;170(1):119-35. doi: 10.1016/s0022-2836(83)80229-0.
Two bacteriophage T4 proteins which are precursors to the phage baseplate have been purified to homogeneity. These proteins, P10 and P11, are components of the P(10/11) complex, which is the first intermediate in the assembly of T4 baseplate 1/6th arms. Each protein was isolated from cells infected with a T4 amber mutant defective in the production of the other protein. Thus these purified proteins have never been assembled into the P(10/11) complex in vivo. Sodium dodecyl sulfate/polyacrylamide gel electrophoresis and the ability of these proteins to block the phage killing activity of specific antisera were used to monitor the purification steps. Sedimentation equilibrium experiments reveal a molecular weight of 188,000 g/mol for P10 and 60,000 g/mol for P11. These data together with the previously determined molecular weights of the gene 10 and gene 11 polypeptide chains (King & Mykolajewycz, 1973) and the in vivo assembled P(10/11) complex (Berget & King, 1978b) are consistent with P10 being a dimer of the product of gene 10, P11 being a dimer of the product of gene 11, and P(10/11) being a tetramer containing one of each of these dimers. Purified P10 and P11 are active in assembly because they complement 10- and 11- defective extracts, respectively, to form viable bacteriophage in vitro. Furthermore, these proteins assemble in vitro to form a protein structure identical to the P(10/11) complex formed in vivo as determined by non-denaturing gel electrophoresis. This P(10/11) complex formed in vitro complements 10-/11- defective extracts to form viable phage. The overall extent of this in vitro assembly reaction is not affected by NaCl to 1.5 M or 2% Triton X-100. The reaction is, however, prevented by the denaturing effects of urea and sodium dodecyl sulfate.
两种作为噬菌体基板前体的T4噬菌体蛋白已被纯化至同质。这些蛋白,P10和P11,是P(10/11)复合物的组成部分,该复合物是T4基板1/6臂组装过程中的首个中间体。每种蛋白都是从感染了另一种蛋白生产缺陷型的T4琥珀突变体的细胞中分离出来的。因此,这些纯化的蛋白从未在体内组装成P(10/11)复合物。使用十二烷基硫酸钠/聚丙烯酰胺凝胶电泳以及这些蛋白阻断特定抗血清的噬菌体杀伤活性的能力来监测纯化步骤。沉降平衡实验显示P10的分子量为188,000 g/mol,P11的分子量为60,000 g/mol。这些数据与先前确定的基因10和基因11多肽链的分子量(King和Mykolajewycz,1973年)以及体内组装的P(10/11)复合物(Berget和King,1978b)一致,表明P10是基因10产物的二聚体,P11是基因11产物的二聚体,P(10/11)是包含这两种二聚体各一个的四聚体。纯化的P10和P11在组装中具有活性,因为它们分别补充10缺陷型和11缺陷型提取物,以在体外形成有活力的噬菌体。此外,通过非变性凝胶电泳确定,这些蛋白在体外组装形成与体内形成的P(10/11)复合物相同的蛋白质结构。这种体外形成的P(10/11)复合物补充10缺陷型/11缺陷型提取物以形成有活力的噬菌体。该体外组装反应的总体程度不受1.5 M NaCl或2% Triton X-100的影响。然而,该反应会被尿素和十二烷基硫酸钠的变性作用所阻止。